Portal venous territories provide the anatomical boundaries for selecting the liver tissue to remove. The surgeon identifies the portal pedicle associated with the lesion’s territory, divides it, and follows the resulting demarcation during transection. This sequence aligns the resection with the lesion’s vascular territory, supporting targeted removal while conserving viable liver parenchyma.
The portal pedicle links the planned resection to the liver’s segmental organization. Once the corresponding pedicle is identified and divided, the involved territory becomes demarcated from surrounding tissue. That boundary guides the transection line and helps the surgeon remove the intended segment, section, or lobe rather than extending the operation beyond the relevant anatomical territory.
Control of blood vessels and bile ducts is integrated into the transection process. Managing the vessels helps limit bleeding as liver tissue is divided, while addressing the bile ducts supports controlled removal of the planned territory. These steps connect the anatomical plan with preservation of viable tissue and with completion of the intended resection.
Preserving viable liver parenchyma is particularly important when chronic liver disease is present. Anatomical targeting allows the surgeon to match tissue removal to the lesion’s vascular territory while conserving liver tissue outside that territory. This balance supports complete removal of the intended lesion or tumor and retains as much functional parenchyma as possible.
The operative sequence begins by identifying the portal pedicle corresponding to the target liver territory. The pedicle is then divided, producing a demarcated area that guides liver transection. During tissue division, the surgeon controls relevant blood vessels and bile ducts. The procedure therefore combines anatomical identification, territory-based transection, and management of structures that could affect bleeding or tissue preservation.
The principal applications include hepatocellular carcinoma and metastatic tumors. Surgeons may also use the approach for selected benign lesions and traumatic lesions when removal is appropriate. Its anatomical basis is relevant across these indications because the planned tissue removal follows the lesion’s segmental or portal territory rather than treating the liver as an undivided organ.
Anatomical targeting can support complete tumor removal while limiting the amount of uninvolved liver removed. By following the portal territory associated with the lesion, the surgeon can transect along a defined boundary and preserve viable parenchyma beyond it. This balance is especially relevant when maintaining functional liver tissue is an important clinical consideration.